{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:07:19Z","timestamp":1791493639180,"version":"4.3.4"},"reference-count":211,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The female reproductive system (FRS) exhibits unique immunological characteristics, balancing defense against pathogens with tolerance to sperm and semi-allogeneic embryos. Key players include decidual natural killer (dNK) cells, immune checkpoint molecules (ICMs) and a complex immune microenvironment (IME). Dysregulation of these elements contributes to diseases like recurrent spontaneous abortion (RSA), endometriosis, primary ovarian insufficiency (POI), and infertility. Immunotherapy, particularly immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T-cell therapy, shows significant promise in treating gynecological malignancies (e.g., cervical, endometrial, ovarian cancers), especially in advanced\/recurrent settings or with specific biomarkers like mismatch repair deficiency. However, challenges persist, including limited efficacy in microsatellite stable tumors, resistance mechanisms and significant immune-related adverse events (irAEs). Critically, emerging evidence indicates potential detrimental effects of immunotherapy (especially ICIs) on female reproductive function, including diminished ovarian reserve, impaired oocyte maturation, hormonal disruption, and possible infertility, mediated by inflammatory responses, gonadotoxicity, and disruption of immune tolerance. Management of female-specific toxicities requires personalized strategies, fertility assessment, and consideration of preservation techniques. Future directions emphasize the development of predictive biomarkers, optimization of combination therapies, and implementation of truly individualized treatment regimens that account for the unique FRS IME, sex hormone influences, and the imperative to preserve fertility. Addressing the reproductive toxicity of novel immunotherapies remains a critical unmet research need.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1658681","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:33:58Z","timestamp":1759383238000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The dual nature of immunotherapy in female reproductive disorders: immune homeostasis and clinical challenges"],"prefix":"10.3389","volume":"16","author":[{"given":"Yiliminuer","family":"Abulajiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"B1","volume-title":"Immunology at the Maternal-Fetal Interface","author":"Balasundaram","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI68107","article-title":"Uterine NK cells: active regulators at the maternal-fetal interface","volume":"124","author":"Moffett","year":"2014","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2010.00847.x","article-title":"Immunological modes of pregnancy loss","volume":"63","author":"Kwak-Kim","year":"2010","journal-title":"Am J Reprod Immunol (New York NY: 1989)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0606","article-title":"SWOG\/NCI phase II dual anti-CTLA-4\/PD-1 blockade in rare tumors: nonepithelial ovarian cancer","volume":"30","author":"Chae","year":"2024","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01934-0","article-title":"Treatment of ovarian cancer beyond PARP inhibition: current and future options","volume":"83","author":"Garg","year":"2023","journal-title":"Drugs"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00635","article-title":"The immune system is a natural target for estrogen action: opposing effects of estrogen in two prototypical autoimmune diseases","volume":"6","author":"Khan","year":"2015","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jri.2018.09.050","article-title":"IntralipidB. may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activation","volume":"130","author":"L\u00e9d\u00e9e","year":"2018","journal-title":"J Reprod Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13755","article-title":"The function of decidua natural killer cells in physiology and pathology of pregnancy","volume":"90","author":"Jin","year":"2023","journal-title":"Am J Reprod Immunol (New York NY: 1989)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1136652","article-title":"Unique metabolism and protein expression signature in human decidual NK cells","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cells11172690","article-title":"IL-10 producing B cells protect against LPS-induced murine preterm birth by promoting PD1- and ICOS-expressing T cells","volume":"11","author":"Busse","year":"2022","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiaf020","article-title":"Different behavior of NK cells isolated from healthy women and women with recurrent spontaneous abortion after treatment with human amniotic epithelial cells","volume":"117","author":"Rezayat","year":"2025","journal-title":"J Leukoc Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/humrep\/dey347","article-title":"The role of the PD-1\/PD-L1 axis in macrophage differentiation and function during pregnancy","volume":"34","author":"Zhang","year":"2019","journal-title":"Hum Reprod (Oxford England)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.763067","article-title":"Cytochrome P450 26A1 modulates the polarization of uterine macrophages during the peri-implantation period","volume":"12","author":"Ji","year":"2021","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772729","article-title":"Pro-inflammatory signature in decidua of recurrent pregnancy loss regardless of embryonic chromosomal abnormalities","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s12967-025-06460-z","article-title":"Characteristics of the vaginal microbiota associated with recurrent spontaneous preterm birth: a prospective cohort study","volume":"23","author":"Jiang","year":"2025","journal-title":"J Trans Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12916-021-02227-7","article-title":"Chromosomally normal miscarriage is associated with vaginal dysbiosis and local inflammation","volume":"20","author":"Grewal","year":"2022","journal-title":"BMC Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1325565","article-title":"Morphology of the immune cells in the wall of the human uterine tube and their possible impact on reproduction-uterine tube as a possible immune privileged organ","volume":"12","author":"Visnyaiov\u00e1","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1038\/s41598-020-62593-9","article-title":"Human Chorionic Gonadotropin modulates CXCL10 Expression through Histone Methylation in human decidua","volume":"10","author":"Silasi","year":"2020","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02890","article-title":"The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions","volume":"9","author":"Szekeres-Bartho","year":"2018","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.180609","article-title":"HIV-1 latency reversal and immune enhancing activity of IL-15 is not influenced by sex hormones","volume":"9","author":"Holmberg","year":"2024","journal-title":"JCI Insight"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02072-w","article-title":"B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer","volume":"46","author":"Li","year":"2023","journal-title":"J endocrinological Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030828","article-title":"Characterization of estrogen receptors in pancreatic adenocarcinoma with tertiary lymphoid structures","volume":"15","author":"Zou","year":"2023","journal-title":"Cancers"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5146\/tjpath.2025.13658","article-title":"Role of PD-L1 in the pathogenesis of pre-eclampsia and its association with adverse fetal outcomes","volume":"1","author":"Tripathi","year":"2025","journal-title":"Turk patoloji dergisi"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1142","article-title":"Immune checkpoint molecules B7\u20131 and B7-H1 as predictive markers of pre-eclampsia: A case-control study in a Ghana","volume":"12","author":"Akilla","year":"2024","journal-title":"Immunity Inflammation Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2024.06.012","article-title":"Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance","volume":"187","author":"Yu","year":"2024","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa223","article-title":"Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts","volume":"35","author":"Hu","year":"2020","journal-title":"Hum Reprod (Oxford England)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e32500","DOI":"10.1097\/MD.0000000000032500","article-title":"A review of autoimmunity and immune profiles in patients with primary ovarian insufficiency","volume":"101","author":"Chen","year":"2022","journal-title":"Medicine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.448","article-title":"T(reg) deficiency-mediated T(H) 1 response causes human premature ovarian insufficiency through apoptosis and steroidogenesis dysfunction of granulosa cells","volume":"11","author":"Jiao","year":"2021","journal-title":"Clin Trans Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41420-021-00566-1","article-title":"Primate-specific POTE-actin gene could play a role in human folliculogenesis by controlling the proliferation of granulosa cells","volume":"7","author":"Kasahara","year":"2021","journal-title":"Cell Death Discov"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.1038\/s41467-021-27035-8","article-title":"Follicular T cells are clonally and transcriptionally distinct in B cell-driven mouse autoimmune disease","volume":"12","author":"Akama-Garren","year":"2021","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae828","article-title":"Autoimmune disease is increased in women with primary ovarian insufficiency","volume":"110","author":"Wang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/4.4.360","article-title":"Is adenomyosis an immune disease","volume":"4","author":"Ota","year":"1998","journal-title":"Hum Reprod Update"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmaa038","article-title":"Immunological changes associated with adenomyosis: a systematic review","volume":"27","author":"Bourdon","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jri.2011.12.001","article-title":"The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: adenomyosis and macrophages","volume":"93","author":"Tremellen","year":"2012","journal-title":"J Reprod Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/4.5.702","article-title":"Phenotypic and functional studies of leukocytes in human endometrium and endometriosis","volume":"4","author":"Jones","year":"1998","journal-title":"Hum Reprod Update"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh372","article-title":"Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis","volume":"19","author":"Yang","year":"2004","journal-title":"Hum Reprod (Oxford England)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671201","article-title":"Identification and validation of the signatures of infiltrating immune cells in the eutopic endometrium endometria of women with endometriosis","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711231","article-title":"A history of endometriosis is associated with decreased peripheral NK cytotoxicity and increased infiltration of uterine CD68(+) macrophages","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1297484","article-title":"Immune and oxidative stress disorder in ovulation-dysfunction women revealed by single-cell transcriptome","volume":"14","author":"Qi","year":"2023","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"117553","DOI":"10.1016\/j.biopha.2024.117553","article-title":"Advancements in nano-immunotherapy for gynecological cancers: A new frontier","volume":"180","author":"Gu","year":"2024","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70210","article-title":"CAR-NK, a splendid strategy for cancer, especially for gynecologic tumor","volume":"13","author":"Cao","year":"2025","journal-title":"Immunity Inflammation Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/life14030344","article-title":"Immunotherapy in cervical and endometrial cancer: current landscape and future directions","volume":"14","author":"Stefanoudakis","year":"2024","journal-title":"Life (Basel)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12032-024-02337-1","article-title":"Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review","volume":"41","author":"Dasgupta","year":"2024","journal-title":"Med Oncol (Northwood London England)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"104063","DOI":"10.1016\/j.critrevonc.2023.104063","article-title":"Advances in immunotherapy for gynecological Malignancies","volume":"188","author":"Tu","year":"2023","journal-title":"Crit Rev oncology\/hematology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/1750743X.2025.2460964","article-title":"Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trials","volume":"17","author":"Nasso","year":"2025","journal-title":"Immunotherapy"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02942-7","article-title":"Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses","volume":"30","author":"Friedman","year":"2024","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003156","article-title":"Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological Malignancies: results of the CA209\u2013538 clinical trial","volume":"9","author":"Klein","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003683","article-title":"Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups","volume":"9","author":"Hsiehchen","year":"2021","journal-title":"J Immunotherapy Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3915","article-title":"Safety, efficacy, and biomarker analyses of dostarlimab in patients with endometrial cancer: interim results of the phase I GARNET study","volume":"29","author":"Oaknin","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2701","article-title":"Mesothelin-specific CAR T cells target ovarian cancer","volume":"81","author":"Schoutrop","year":"2021","journal-title":"Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2093426","DOI":"10.1080\/2162402X.2022.2093426","article-title":"Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality","volume":"11","author":"Schoutrop","year":"2022","journal-title":"Oncoimmunology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"110562","DOI":"10.1016\/j.biopha.2020.110562","article-title":"Novel cellular immunotherapy using NKG2D CAR-T for the treatment of cervical cancer","volume":"131","author":"Zhang","year":"2020","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43018-022-00413-x","article-title":"Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice","volume":"3","author":"Winship","year":"2022","journal-title":"Nat Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e27832","DOI":"10.1016\/j.heliyon.2024.e27832","article-title":"Knowledge domains and emerging trends in immune-related adverse events from immune checkpoint inhibitors: A bibliometrics and visualized analysis","volume":"10","author":"Zhao","year":"2024","journal-title":"Heliyon"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17683","article-title":"Cutaneous side effects of PD-1 inhibitors: A single-center retrospective study","volume":"64","author":"Pozsgai","year":"2025","journal-title":"Int J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2174\/0115748871340496250130054721","article-title":"Immune checkpoint inhibitors impact fertility: A review","author":"Shabir","year":"2025","journal-title":"Rev Recent Clin Trials"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2024.101453","article-title":"Pembrolizumab-induced myasthenia gravis: Two patients\u2019 experiences","volume":"54","author":"Montag","year":"2024","journal-title":"Gynecologic Oncol Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12328-022-01731-4","article-title":"Immune-related colitis and pancreatitis treated with infliximab","volume":"16","author":"Ohwada","year":"2023","journal-title":"Clin J Gastroenterol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006624","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer","volume":"11","author":"Disis","year":"2023","journal-title":"J Immunotherapy Cancer"},{"key":"B62","doi-asserted-by":"publisher","first-page":"155202","DOI":"10.1016\/j.prp.2024.155202","article-title":"TIGIT: A potential immunotherapy target for gynecological cancers","volume":"255","author":"Jiang","year":"2024","journal-title":"Pathology Res Pract"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2023.2281482","article-title":"The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers","volume":"23","author":"Tsunedomi","year":"2023","journal-title":"Expert Rev Mol diagnostics"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1328651","article-title":"Targeting the immune microenvironment for ovarian cancer therapy","volume":"14","author":"Blanc-Durand","year":"2023","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-025-07818-3","article-title":"KDM6A downregulation promotes tumor-prone cytokines expression in cancer-associated fibroblasts by activating enhancers","volume":"16","author":"Zhang","year":"2025","journal-title":"Cell Death Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122750","article-title":"Tumor microenvironment immunomodulation by nanoformulated TLR 7\/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy","volume":"312","author":"Yazdimamaghani","year":"2025","journal-title":"Biomaterials"},{"key":"B67","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/ijgc-2023-004842","article-title":"Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic Malignancies: a case series","volume":"34","author":"Sia","year":"2024","journal-title":"Int J Gynecological Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2570","article-title":"Bridging the gap from bench to bedside: A call for in vivo preclinical models to advance endometrial cancer and cervical cancer immuno-oncology research","volume":"30","author":"Chambers","year":"2024","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30436-8","article-title":"Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial","volume":"21","author":"Powles","year":"2020","journal-title":"Lancet Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-020-15315-8","article-title":"Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer","volume":"11","author":"F\u00e4rkkil\u00e4","year":"2020","journal-title":"Nat Commun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0056","article-title":"Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase II study","volume":"26","author":"Lampert","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1186\/s12885-022-10133-1","article-title":"Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study","volume":"22","author":"Kurokawa","year":"2022","journal-title":"BMC Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-004073","article-title":"Endometrial carcinosarcoma","volume":"33","author":"Bogani","year":"2023","journal-title":"Int J gynecological Cancer"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1200\/JCO.2017.35.15_suppl.3548","article-title":"Concordance of DNA mismatch repair deficient (dMMR)\/microsatellite instability (MSI) assessment by local and central testing in patients with metastatic CRC (mCRC) receiving nivolumab (nivo) in CheckMate 142 study","volume":"35","author":"Kopetz","year":"2017","journal-title":"J Clin Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2021.828","article-title":"Frequency of mismatch repair deficiency\/high microsatellite instability and its role as a predictive biomarker of response to immune checkpoint inhibitors in gynecologic cancers","volume":"54","author":"Noh","year":"2022","journal-title":"Cancer Res Treat"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1392639","article-title":"Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy","volume":"14","author":"Galicia-Carmona","year":"2024","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1454372","article-title":"Efficacy of PD-1 or PD-L1 inhibitors for the therapy of cervical cancer with varying PD-L1 expression levels: a single-arm meta-analysis","volume":"14","author":"Yang","year":"2024","journal-title":"Front Oncol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020401","article-title":"PD-1 and PD-L1 expression in endometrial cancer: A systematic review of the literature","volume":"14","author":"De Tommasi","year":"2025","journal-title":"J Clin Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1391524","article-title":"Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009143","article-title":"Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer","volume":"12","author":"Grau Bejar","year":"2024","journal-title":"J immunotherapy Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13046-024-03046-3","article-title":"CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy","volume":"43","author":"Qu","year":"2024","journal-title":"J Exp Clin Cancer research: CR"},{"key":"B82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00262-024-03881-5","article-title":"High CD38 expression defines a mitochondrial function-adapted CD8(+) T cell subset with implications for lung cancer immunotherapy","volume":"74","author":"Lv","year":"2025","journal-title":"Cancer immunology immunotherapy: CII"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240559","article-title":"tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells","volume":"222","author":"Miao","year":"2025","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ado2463","article-title":"CCR8(+) decidual regulatory T cells maintain maternal-fetal immune tolerance during early pregnancy","volume":"10","author":"Li","year":"2025","journal-title":"Sci Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179378","article-title":"Surface immune checkpoints as potential biomarkers in physiological pregnancy and recurrent pregnancy loss","volume":"25","author":"Zych","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1530\/RAF-24-0034","article-title":"Comparing surface immune markers in successful and non-viable ART pregnancies on the day of hCG measurement: a prospective pilot study","volume":"6","author":"Marron","year":"2025","journal-title":"Reprod fertility"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead178","article-title":"Decreased serum soluble programmed cell death ligand-1 level as a potential biomarker for missed miscarriage","volume":"38","author":"Li","year":"2023","journal-title":"Hum Reprod"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e16151","DOI":"10.1111\/jog.16151","article-title":"Effect of vitamin D adjuvant therapy on the proportion of regulatory T cells in peripheral blood and pregnancy outcome of patients with recurrent miscarriage","volume":"51","author":"Ling","year":"2025","journal-title":"J Obstet Gynaecol Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104785","article-title":"A new approach to the treatment of ovarian cancer: The application of CAR-T cell therapy","volume":"213","author":"Yang","year":"2025","journal-title":"Crit Rev oncology\/hematology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13073-024-01405-5","article-title":"Efficacy and safety of novel multiple-chain DAP-CAR-T cells targeting mesothelin in ovarian cancer and mesothelioma: a single-arm, open-label and first-in-human study","volume":"16","author":"Xu","year":"2024","journal-title":"Genome Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70106","article-title":"Ligand-based CAR-T cells targeting EGFR exhibit favorable antitumor effects against gynecologic Malignancies","volume":"116","author":"Shinagawa","year":"2025","journal-title":"Cancer Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14541","article-title":"Overexpression of SMAD7 improves the function of EGFR-targeted human CAR-T cells against non-small-cell lung cancer","volume":"28","author":"Li","year":"2023","journal-title":"Respirology (Carlton Vic)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16285","article-title":"Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T-cell therapy in solid tumors","volume":"115","author":"Meng","year":"2024","journal-title":"Cancer Sci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ymthe.2024.12.014","article-title":"Potentiating CAR-T cell function in the immunosuppressive tumor microenvironment by inverting the TGF-N2 signal","volume":"33","author":"Zheng","year":"2025","journal-title":"Mol therapy: J Am Soc Gene Ther"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1506204","article-title":"Relaxin-2-secreting CAR-T cells exhibit enhanced efficacy in stromal-rich xenograft tumors","volume":"16","author":"Ogawa","year":"2025","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233769","article-title":"Dynamic changes in the extracellular matrix in primary, metastatic, and recurrent ovarian cancers","volume":"11","author":"Gertych","year":"2022","journal-title":"Cells"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1302307","article-title":"CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer","volume":"14","author":"Nasiri","year":"2023","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"104680","DOI":"10.1016\/j.critrevonc.2025.104680","article-title":"Chimeric antigen receptor T cell immunotherapy for gynecological Malignancies","volume":"209","author":"Gao","year":"2025","journal-title":"Crit Rev oncology\/hematology"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02444-y","article-title":"Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy","volume":"38","author":"Lei","year":"2024","journal-title":"Leukemia"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126595","article-title":"A review of CAR-T combination therapies for treatment of gynecological cancers","volume":"25","author":"Olifirenko","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaf096","article-title":"Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies","volume":"40","author":"Arecco","year":"2025","journal-title":"Hum Reprod (Oxford England)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.06.006","article-title":"Pediatric cancer immunotherapy and potential for impact on fertility: A need for evidence-based guidance","volume":"30","author":"Ligon","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12576-024-00950-3","article-title":"The potential role of exercise in mitigating fertility toxicity associated with immune checkpoint inhibitors (ICIs) in cancer patients","volume":"74","author":"Jamrasi","year":"2024","journal-title":"J Physiol sciences: JPS"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-025-01299-4","article-title":"Fertility sparing medical management options in gynecologic cancers","volume":"26","author":"Kouri","year":"2025","journal-title":"Curr Treat options Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114010","article-title":"Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors","volume":"202","author":"Helgadottir","year":"2024","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1108163","article-title":"Uterine NK cells underexpress KIR2DL1\/S1 and LILRB1 in reproductive failure","volume":"13","author":"Woon","year":"2022","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/life13051097","article-title":"Immune cell functionality during decidualization and potential clinical application","volume":"13","author":"Stope","year":"2023","journal-title":"Life (Basel)"},{"key":"B109","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.4081\/aiua.2024.12307","article-title":"The role of immunotherapy in urological cancers","volume":"96","author":"Bosnali","year":"2024","journal-title":"Archivio italiano di urologia andrologia: organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2023e12703","article-title":"Immuno-oncology in head and neck squamous cell carcinoma - a narrative review","volume":"56","author":"Silva","year":"2023","journal-title":"Braz J Med Biol Res = Rev Bras Pesquisas M\u00e9dicas e Biol\u00f3gicas"},{"key":"B111","doi-asserted-by":"publisher","first-page":"100573","DOI":"10.1016\/j.medj.2024.100573","article-title":"IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent\/metastatic cervical cancer: A double-blind, randomized controlled trial","volume":"6","author":"Li","year":"2025","journal-title":"Med (New York NY)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00079","article-title":"Pembrolizumab plus ipilimumab following anti-PD-1\/L1 failure in melanoma","volume":"39","author":"Olson","year":"2021","journal-title":"J Clin Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1039\/D0BM02210A","article-title":"A highly stable multifunctional aptamer for enhancing antitumor immunity against hepatocellular carcinoma by blocking dual immune checkpoints","volume":"9","author":"Du","year":"2021","journal-title":"Biomaterials Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1534975","article-title":"Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility in-vitro","volume":"16","author":"Cosci","year":"2025","journal-title":"Front Pharmacol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063105","article-title":"Strategies for overcoming immune evasion in bladder cancer","volume":"25","author":"Shin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1345838","article-title":"Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/d41591-022-00095-z","article-title":"Impact of cancer immunotherapy on female fertility","author":"O\u2019Leary","year":"2022","journal-title":"Nat Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/JOE-21-0209","article-title":"Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse","volume":"252","author":"Xu","year":"2021","journal-title":"J Endocrinol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"115206","DOI":"10.1016\/j.celrep.2024.115206","article-title":"Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets","volume":"44","author":"Ricci","year":"2025","journal-title":"Cell Rep"},{"key":"B120","doi-asserted-by":"publisher","first-page":"103796","DOI":"10.1016\/j.redox.2025.103796","article-title":"Ferroptosis triggers anti-tumor immunity via promoting chaperone-mediated autophagic degradation of SHP2","volume":"86","author":"Zhu","year":"2025","journal-title":"Redox Biol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00262-025-04133-w","article-title":"GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis","volume":"74","author":"K\u0142opotowska","year":"2025","journal-title":"Cancer immunology immunotherapy: CII"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/life13051209","article-title":"The impact of systemic oncological treatments on the fertility of adolescents and young adults-A systematic review","volume":"13","author":"Himpe","year":"2023","journal-title":"Life (Basel)"},{"key":"B123","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41420-024-01818-6","article-title":"Targeted immunotherapy: harnessing the immune system to battle multiple myeloma","volume":"10","author":"Xu","year":"2024","journal-title":"Cell Death Discov"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00469","article-title":"Minding the bathwater: fertility and reproductive toxicity in the age of immuno-oncology","volume":"18","author":"Kim","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"B125","doi-asserted-by":"publisher","first-page":"116009","DOI":"10.1016\/j.ecoenv.2024.116009","article-title":"The association between prenatal bisphenol F exposure and infant neurodevelopment: The mediating role of placental estradiol","volume":"271","author":"Dou","year":"2024","journal-title":"Ecotoxicology Environ Saf"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30110684","article-title":"Cancer and pregnancy in the post-roe v","volume":"30","author":"Arup","year":"2023","journal-title":"Wade Era: A Compr Rev [J]. Curr Oncol (Toronto Ont)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417193","article-title":"The role of cellular senescence in cyclophosphamide-induced primary ovarian insufficiency","volume":"24","author":"Xu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B128","doi-asserted-by":"publisher","first-page":"28479","DOI":"10.1038\/s41598-024-79532-7","article-title":"Mechanism of action of Salvia miltiorrhiza on avascular necrosis of the femoral head determined by integrated network pharmacology and molecular dynamics simulation","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14040431","article-title":"Fertility preservation in the era of immuno-oncology: lights and shadows","volume":"14","author":"Silvestris","year":"2024","journal-title":"J personalized Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.179233","article-title":"IL-27\/Blimp-1 axis regulates the differentiation and function of Tim-3+ Tregs during early pregnancy","volume":"9","author":"Zhao","year":"2024","journal-title":"JCI Insight"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092106","article-title":"The effects of cancer immunotherapy on fertility: focus on hematological Malignancies","volume":"12","author":"Caserta","year":"2024","journal-title":"Biomedicines"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010599","article-title":"Cutaneous melanoma and hormones: focus on sex differences and the testis","volume":"24","author":"Cosci","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129815","article-title":"The thyroid hormone axis and female reproduction","volume":"24","author":"Brown","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c01399","article-title":"A quadruplex ultrasensitive immunoassay for simultaneous assessment of human reproductive hormone proteins in multiple biofluid samples","volume":"95","author":"Cai","year":"2023","journal-title":"Analytical Chem"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033113","article-title":"Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis","volume":"102","author":"Guo","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2024187","article-title":"The effect of norepinephrine on ovarian dysfunction by mediating ferroptosis in mice model","volume":"57","author":"Hong","year":"2024","journal-title":"Acta Biochim Biophys Sin"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886645","article-title":"Double negative T regulatory cells: an emerging paradigm shift in reproductive immune tolerance","volume":"13","author":"Bafor","year":"2022","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2022.12.105","article-title":"Iron overload modulates follicular microenvironment via ROS\/HIF-1N1\/FSHR signaling","volume":"196","author":"Wu","year":"2023","journal-title":"Free Radical Biol Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jare.2023.11.008","article-title":"In pre-clinical study fetal hypoxia caused autophagy and mitochondrial impairment in ovary granulosa cells mitigated by melatonin supplement","volume":"64","author":"Zhang","year":"2024","journal-title":"J Advanced Res"},{"key":"B140","doi-asserted-by":"publisher","first-page":"104064","DOI":"10.1016\/j.critrevonc.2023.104064","article-title":"Immune checkpoint inhibitors as a threat to reproductive function: A systematic review","volume":"188","author":"Tuerxun","year":"2023","journal-title":"Crit Rev oncology\/hematology"},{"key":"B141","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13048-025-01683-6","article-title":"LncRNA NEAT1 participates in diminished ovarian reserve by affecting granulosa cell apoptosis and estradiol synthesis via the miR-204-5p\/ESR1 axis","volume":"18","author":"Dong","year":"2025","journal-title":"J Ovarian Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1160258","article-title":"Ovarian dysfunction in women with Turner syndrome","volume":"14","author":"Fukami","year":"2023","journal-title":"Front Endocrinol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1109122","article-title":"Roles of immune microenvironment in the female reproductive maintenance and regulation: novel insights into the crosstalk of immune cells","volume":"14","author":"Dai","year":"2023","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"104262","DOI":"10.1016\/j.jri.2024.104262","article-title":"Innate and adaptive immune dysregulation in women with recurrent implantation failure","volume":"164","author":"Ebrahimi","year":"2024","journal-title":"J Reprod Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305175","article-title":"Single-cell atlas of human ovaries reveals the role of the pyroptotic macrophage in ovarian aging","volume":"11","author":"Zhou","year":"2024","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13059-024-03464-8","article-title":"Spatiotemporal dynamics of early oogenesis in pigs","volume":"26","author":"Ge","year":"2025","journal-title":"Genome Biol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1324429","article-title":"Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging","volume":"14","author":"Orisaka","year":"2023","journal-title":"Front Endocrinol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"rbad033","DOI":"10.1093\/rb\/rbad033","article-title":"Recombinant humanized collagen remodels endometrial immune microenvironment of chronic endometritis through macrophage immunomodulation","volume":"10","author":"You","year":"2023","journal-title":"Regenerative biomaterials"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-024-01997-8","article-title":"Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects","volume":"29","author":"Lu","year":"2024","journal-title":"Apoptosis: an Int J programmed Cell Death"},{"key":"B150","doi-asserted-by":"publisher","first-page":"115251","DOI":"10.1016\/j.biopha.2023.115251","article-title":"Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be","volume":"165","author":"Zhou","year":"2023","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"B151","doi-asserted-by":"publisher","first-page":"368504241237888","DOI":"10.1177\/00368504241237888","article-title":"Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"107","author":"Zhu","year":"2024","journal-title":"Sci Prog"},{"key":"B152","doi-asserted-by":"publisher","first-page":"7770","DOI":"10.1038\/s41598-025-91476-0","article-title":"Pharmacovigilance analysis of immune checkpoint inhibitor-related reproductive adverse effects based on the FDA adverse event reporting system","volume":"15","author":"Koylu","year":"2025","journal-title":"Sci Rep"},{"key":"B153","doi-asserted-by":"publisher","first-page":"170543","DOI":"10.1016\/j.scitotenv.2024.170543","article-title":"Advances in polychlorinated biphenyls-induced female reproductive toxicity","volume":"918","author":"Wu","year":"2024","journal-title":"Sci Total Environ"},{"key":"B154","doi-asserted-by":"publisher","first-page":"115201","DOI":"10.1016\/j.fct.2024.115201","article-title":"Triptolide exposure triggers ovarian inflammation by activating cGAS-STING pathway and decreases oocyte quality in mouse","volume":"196","author":"Cheng","year":"2025","journal-title":"Food Chem Toxicology: Int J Published Br Ind Biol Res Assoc"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.4c08701","article-title":"Per- and polyfluoroalkyl substances and female health concern: gender-based accumulation differences, adverse outcomes, and mechanisms","volume":"59","author":"Li","year":"2025","journal-title":"Environ Sci Technol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010168","article-title":"Immunotherapy in recurrent ovarian cancer","volume":"13","author":"Chen","year":"2025","journal-title":"Biomedicines"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1583592","article-title":"Incidence of thyroid adverse events following immune checkpoint inhibitor treatment in patients with baseline positive thyroid antibodies: a systematic review and meta-analysis","volume":"15","author":"Yu","year":"2025","journal-title":"Front Oncol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"bvad012","DOI":"10.1210\/jendso\/bvad012","article-title":"Spectrum of clinical presentations, imaging findings, and HLA types in immune checkpoint inhibitor-induced hypophysitis","volume":"7","author":"Quandt","year":"2023","journal-title":"J Endocrine Soc"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: A systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0238","article-title":"Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis","volume":"181","author":"Faje","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.6.759","article-title":"Complement and cellular cytotoxicity in antibody therapy of cancer","volume":"8","author":"Wang","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600614","article-title":"Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells","volume":"87","author":"Junnikkala","year":"2002","journal-title":"Br J Cancer"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.05.031","article-title":"Insights into the role of complement regulatory proteins in HPV mediated cervical carcinogenesis","volume":"86","author":"Khan","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1655","article-title":"Modulation of the antitumor immune response by complement","volume":"9","author":"Markiewski","year":"2008","journal-title":"Nat Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B166","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1593\/neo.121262","article-title":"Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization","volume":"14","author":"Nunez-Cruz","year":"2012","journal-title":"Neoplasia (New York NY)"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01074","article-title":"The role of membrane bound complement regulatory proteins in tumor development and cancer immunotherapy","volume":"10","author":"Geller","year":"2019","journal-title":"Front Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1579-y","article-title":"Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with Malignant and benign ovarian tumours","volume":"63","author":"Swierzko","year":"2014","journal-title":"Cancer immunology immunotherapy: CII"},{"key":"B169","doi-asserted-by":"publisher","first-page":"107628","DOI":"10.1016\/j.celrep.2020.107628","article-title":"Single-cell RNA sequencing reveals a dynamic stromal niche that supports tumor growth","volume":"31","author":"Davidson","year":"2020","journal-title":"Cell Rep"},{"key":"B170","doi-asserted-by":"publisher","first-page":"33346","DOI":"10.1038\/srep33346","article-title":"Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1\/2 and JNK signaling pathways","volume":"6","author":"An","year":"2016","journal-title":"Sci Rep"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1349587","article-title":"Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1\/PD-L1 blockade","volume":"6","author":"Zha","year":"2017","journal-title":"Oncoimmunology"},{"key":"B172","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1158\/2159-8290.CD-16-1184","article-title":"A combined PD-1\/C5a blockade synergistically protects against lung cancer growth and metastasis","volume":"7","author":"Ajona","year":"2017","journal-title":"Cancer Discov"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10235","article-title":"PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096723","article-title":"Normal human pregnancy results in maternal immune activation in the periphery and at the uteroplacental interface","volume":"9","author":"Loewendorf","year":"2014","journal-title":"PloS One"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1002\/jat.4406","article-title":"The effects of natural products and bioactive ingredients of traditional Chinese medicine on apoptosis of ovarian granulosa cells","volume":"43","author":"Zhong","year":"2023","journal-title":"J Appl toxicology: JAT"},{"key":"B176","doi-asserted-by":"publisher","first-page":"125210","DOI":"10.1016\/j.envpol.2024.125210","article-title":"Curcumin protects porcine granulosa cells and mouse ovary against reproductive toxicity of aflatoxin B1 via PI3K\/AKT signaling pathway","volume":"363","author":"Li","year":"2024","journal-title":"Environ pollut (Barking Essex: 1987)"},{"key":"B177","doi-asserted-by":"publisher","first-page":"177920","DOI":"10.1016\/j.scitotenv.2024.177920","article-title":"Tri-o-tolyl phosphate impedes implantation: Malfunction of mitochondria and disruption of calcium homeostasis through MAPK and AKT signaling cascades","volume":"958","author":"Park","year":"2025","journal-title":"Sci total Environ"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.7150\/thno.102626","article-title":"Engineering nanosystems for regulating reproductive health in women","volume":"15","author":"Fu","year":"2025","journal-title":"Theranostics"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2025.102603","article-title":"Can we really protect the ovary from chemotherapy damage","volume":"99","author":"Nguyen","year":"2025","journal-title":"Best Pract Res Clin obstetrics gynaecology"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1159\/000541615","article-title":"Oocyte quality in women with endometriosis","volume":"90","author":"Trinchant","year":"2025","journal-title":"Gynecologic obstetric Invest"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000951","article-title":"Current applications of artificial intelligence in assisted reproductive technologies through the perspective of a patient\u2019s journey","volume":"36","author":"Pavlovic","year":"2024","journal-title":"Curr Opin obstetrics gynecology"},{"key":"B182","doi-asserted-by":"publisher","first-page":"108599","DOI":"10.1016\/j.compbiomed.2024.108599","article-title":"Advancing intrauterine adhesion severity prediction: Integrative machine learning approach with hysteroscopic cold knife system, clinical characteristics and hematological parameters","volume":"177","author":"Yang","year":"2024","journal-title":"Comput Biol Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2025.04.029","article-title":"Special considerations in assisted reproductive technology for patients with hematologic disease","volume":"124","author":"Ewy","year":"2025","journal-title":"Fertility sterility"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1219045","article-title":"Fertility loss: negative effects of environmental toxicants on oogenesis","volume":"14","author":"Yao","year":"2023","journal-title":"Front Physiol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.2196\/38535","article-title":"Web-based guidance for assisted reproductive technology with an online app (myFertiCare): quantitative evaluation with the HOT-fit framework","volume":"25","author":"Sparidaens","year":"2023","journal-title":"J Med Internet Res"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1530\/REP-24-0275","article-title":"Key glycometabolism during oocyte maturation and early embryonic development","volume":"169","author":"Zhang","year":"2025","journal-title":"Reprod (Cambridge England)"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac170","article-title":"Fertility and assisted reproductive technologies outcomes of women with non-surgically managed inflammatory bowel diseases: A systematic review","volume":"17","author":"Vieujean","year":"2023","journal-title":"J Crohns Colitis"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S424361","article-title":"Social egg freezing for single women in China: legal and ethical controversies","volume":"16","author":"Zhao","year":"2023","journal-title":"Risk Manage healthcare Policy"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215187","article-title":"Endometrial cancer in reproductive age: fertility-sparing approach and reproductive outcomes","volume":"14","author":"Mutlu","year":"2022","journal-title":"Cancers"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1398078","article-title":"Overview of infectious complications among CAR T-cell therapy recipients","volume":"14","author":"Arya","year":"2024","journal-title":"Front Oncol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10805-5","article-title":"Taming the cytokine storm: small molecule inhibitors targeting IL-6\/IL-6N1 receptor","volume":"28","author":"Zia","year":"2024","journal-title":"Mol Diversity"},{"key":"B193","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13256-025-05081-w","article-title":"Post coronavirus-disease-vaccination immune reconstitution inflammatory syndrome in tuberculosis treatment: a case report","volume":"19","author":"Mehta","year":"2025","journal-title":"J Med Case Rep"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1014","article-title":"The IRIS paradox: Imaging findings in a case of PJP-IRIS","volume":"10","author":"Reddy","year":"2022","journal-title":"Respirology Case Rep"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.64146","article-title":"Immune reconstitution syndrome caused by nontuberculous mycobacteria: A case report and review of literature","volume":"16","author":"Kohli","year":"2024","journal-title":"Cureus"},{"key":"B196","doi-asserted-by":"publisher","first-page":"17588359241297565","DOI":"10.1177\/17588359241297565","article-title":"Different activity and toxicity of immunotherapy in monozygotic twins diagnosed with early triple-negative breast cancer: a case report","volume":"17","author":"Perachino","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000001295","article-title":"Immunotherapy toxicities in genito-urinary cancers: insights and challenges for clinicians","volume":"35","author":"Mercinelli","year":"2025","journal-title":"Curr Opin Urol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"151819","DOI":"10.1016\/j.soncn.2025.151819","article-title":"A shift in practice: A discussion of the impact of immunotherapy on cancer nursing","volume":"41","author":"Bird","year":"2025","journal-title":"Semin Oncol Nurs"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.04.002","article-title":"Immune mechanisms of toxicity from checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Trends Cancer"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46723","article-title":"Paradoxical immune reconstitution inflammatory syndrome in SARS-coV-2 infection after improvement of chemotherapy-induced aplasia","volume":"15","author":"Canelas Mendes","year":"2023","journal-title":"Cureus"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c21055","article-title":"Gold nanoparticles carrying mannose-binding lectin and inflammatory cytokine antibodies improve sepsis survival by modulating immunity and reducing pathogens","volume":"17","author":"Mao","year":"2025","journal-title":"ACS Appl materials interfaces"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163569","article-title":"Gut microbiota and critically ill patients: immunity and its modulation via probiotics and immunonutrition","volume":"15","author":"Abenavoli","year":"2023","journal-title":"Nutrients"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhaf022","article-title":"The role of the dopamine system in autism spectrum disorder revealed using machine learning: an ABIDE database-based study","volume":"35","author":"Li","year":"2025","journal-title":"Cereb Cortex (New York NY: 1991)"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13649","article-title":"Expression and T cell regulatory action of the PD-1 immune checkpoint in the ovary and fallopian tube","volume":"89","author":"Johnson","year":"2023","journal-title":"Am J Reprod Immunol (New York NY: 1989)"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68463","article-title":"Poly(Adenosine diphosphate ribose) polymerase (PARP) inhibitors in the treatment of advanced ovarian cancer: A narrative review","volume":"16","author":"Dewani","year":"2024","journal-title":"Cureus"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1061761","article-title":"Evaluation of immunotherapy efficacy in gynecologic cancer","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1257173","article-title":"Hedgehog signaling and the glioma-associated oncogene in cancer radioresistance","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"0600","DOI":"10.34133\/research.0600","article-title":"Crosstalk between gut microbiota and cancer immunotherapy: present investigations and future perspective","volume":"8","author":"Tang","year":"2025","journal-title":"Res (Washington DC)"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1368572","article-title":"Aberrant CD8(+)T cells drive reproductive dysfunction in female mice with elevated IFN-N3 levels","volume":"15","author":"Bafor","year":"2024","journal-title":"Front Immunol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/17410541.2024.2442897","article-title":"Individualized psychiatric care: integration of therapeutic drug monitoring, pharmacogenomics, and biomarkers","volume":"22","author":"Salatin","year":"2025","journal-title":"Personalized Med"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1007\/102_2024_9","article-title":"The influence of ovarian-derived extracellular vesicles in reproduction","author":"Chaves","year":"2025","journal-title":"Adv anatomy embryology Cell Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1658681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:34:00Z","timestamp":1759383240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1658681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":211,"alternative-id":["10.3389\/fimmu.2025.1658681"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1658681","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1658681"}}